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Central nervous system synapses undergo activity-
dependent alterations to support learning and
memory. Long-term depression (LTD) reflects a sus-
tained reduction of the synaptic AMPA receptor
content based on targeted clathrin-mediated endo-
cytosis. Here we report a current-independent form
of AMPA receptor signaling, fundamental for LTD.
We found that AMPA receptors directly interact via
the GluA2 subunit with the synaptic protein BRAG2,
which functions as a guanine-nucleotide exchange
factor (GEF) for the coat-recruitment GTPase Arf6.
BRAG2-mediated catalysis, controlled by ligand-
binding and tyrosine phosphorylation of GluA2, acti-
vates Arf6 to internalize synaptic AMPA receptors
upon LTD induction. Furthermore, acute blockade
of the GluA2-BRAG2 interaction and targeted dele-
tion of BRAG2 in mature hippocampal CA1 pyramidal
neurons prevents LTD in CA3-to-CA1 cell synapses,
irrespective of the induction pathway. We conclude
that BRAG2-mediated Arf6 activation triggered by
AMPA receptors is the convergent step of different
forms of LTD, thus providing an essential mechanism
for the control of vesicle formation by endocytic
cargo.
INTRODUCTION
AMPA-type glutamate receptors convey the majority of rapid
excitatory neurotransmission in the brain. These ligand-gated,
tetrameric ion channels are composed of subunits GluA1–A4
(GluR-A to -D, GluR1–4) with GluA1A2 and GluA2A3 represent-
ing the principal synaptic assemblies in CA1 pyramidal neurons
(Lu et al., 2009). Trafficking of AMPA receptors (AMPARs) into
and out of the postsynaptic membrane, either by lateral diffusion
within the plasma membrane or by vesicular transport, supports
changes in synaptic strength for learning and memory processes
(Derkach et al., 2007; Kessels and Malinow, 2009; Newpher
and Ehlers, 2008). The major forms of LTD, which are triggered
by NMDA receptor (NMDAR) or metabotropic glutamate recep-
tor (mGluR) activation (Malenka and Bear, 2004), become
expressed as a sustained reduction of the synaptic AMPAR768 Neuron 66, 768–780, June 10, 2010 ª2010 Elsevier Inc.content. This is achieved by clathrin-mediated endocytosis
and relies on sequences within the intracellular C-terminal region
of the GluA2 subunit (GluA2-CT) (Beattie et al., 2000; Lin et al.,
2000; Man et al., 2000). A binding site for the clathrin adaptor
complex AP2 in GluA2-CT is essential for LTD (Lee et al., 2002;
Man et al., 2000), and blockade of AP2 binding in the perirhinal
cortex impaired visual recognition memory in rats (Griffiths
et al., 2008). In addition, a peptide with a tyrosine-rich sequence
motif derived from GluA2-CT blocked LTD and interfered with
select cognitive functions in hippocampus (Ahmadian et al.,
2004; Wong et al., 2007), nucleus accumbens (Brebner et al.,
2005), lateral amygdala (Yu et al., 2008), and medial prefrontal
cortex (Van den Oever et al., 2008). Thus, both AP2 binding
and an unknown signaling event by the tyrosine-rich sequence
of GluA2-CT appear to be required for the expression of LTD in
diverse neuronal circuits.
Synaptic plasticity is accompanied by dynamic phosphoryla-
tion of the C-terminal regions of AMPAR subunits (Malenka
and Bear, 2004), which either changes the open probability or
affects trafficking and stabilization of AMPARs at synaptic or
extrasynaptic sites (Shepherd and Huganir, 2007). The tyro-
sine-rich motif of GluA2-CT is also subject to phosphorylation
(Ahmadian et al., 2004; Hayashi and Huganir, 2004), but the
consequences of this modification remained elusive.
BRAG2/GEP100 is a member of a family of three closely
related proteins and functions as a GEF for Arf6 (Someya et al.,
2001), the principal coat recruitment GTPase at the plasma
membrane (D’Souza-Schorey and Chavrier, 2006). BRAG2-
mediated Arf6 activation is required for myotube fusion (Chen
et al., 2003; Pajcini et al., 2008) and regulates cell adhesion by
triggering membrane trafficking events, including beta 1 integrin
endocytosis (Dunphy et al., 2006). Moreover, BRAG2 is involved
in the invasive activity of breast cancer cells by linking EGF
receptor signaling to Arf6 activation (Morishige et al., 2008).
A role for BRAG2 in the brain has not yet been described,
although Arf6 has been implicated in the recruitment of AP2
and clathrin to synaptic membranes (Krauss et al., 2003).
In cultured neurons, Arf6, activated by other Arf6-GEFs, ARNO,
and EFA6A, controls the development of neurites and dendritic
spines (Choi et al., 2006; Herna´ndez-Deviez et al., 2002).
Notwithstanding the importance of LTD for cognitive functions
and the detailed insight into various LTD induction pathways, the
molecular events actually triggering AMPAR internalization for
LTD have remained enigmatic. Here we show that AMPARs
promote their own endocytosis for LTD through BRAG2-medi-
ated Arf6 activation. We provide evidence that BRAG2 can
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Figure 1. Protein-Protein Interaction be-
tween AMPARs and BRAG2
(A) A tyrosine-rich motif conserved between short-
tailed AMPAR subunits mediates binding to
BRAG2. Shown are C-terminal segments of rat
GluA2 appended to the Gal4 DNA-binding domain.
The ability of these fusion proteins to interact with
a BRAG2 fragment (amino acids 494–861, en-
coded by a prey clone from the screen) in the
Y2H assay is indicated on the right by the growth
of cotransformed yeast colonies spotted on
medium lacking histidine. An 11 amino acid motif
with 3 tyrosine residues (3Y motif, shaded) was
sufficient for binding to the BRAG2 prey. The single
letter sequence of the C-terminal region of rat
GluA2 highlights the amino acids conserved
between GluA2, GluA3, and GluA4short (Gallo
et al., 1992) in bold.
(B) The Sec7-PH module of BRAG2 interacts with
the GluA2 C-terminal domain. The map of BRAG2
highlights the IQ motif, the Sec7 domain, and the
PH domain. The prey protein and three deletion
constructs with the specified amino acids of
BRAG2 are aligned to the domain map. Their ability
to interact with a C-terminal fragment of GluA2
(amino acids 848–883, the bait used for screening)
in the Y2H assay is indicated on the right.
(C) Immunoblots of recombinant BRAG2 recov-
ered by GST pull-down with GluA2-CT, D3Y
(GluA2-CT lacking amino acids 867–877), Y876F,
Y876A, or V875A/Y876V (GluA2-CT with the indi-
cated amino acid changes) from HEK-BRAG2
cells. Input: 2.5%.
(D) Immunoblots of endogenous BRAG2 recov-
ered by GST pull-down with GluA2-CT or D3Y
from mouse forebrain extracts. Input: 2.5%.
(E) Immunoblots of endogenous BRAG2 coimmu-
noprecipitated (IP) by an antibody to GluA2 or
control IgG from cultured hippocampal neurons.
Input: 2%.
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AMPARs Directly Trigger BRAG2 Catalysis for LTDbind to synaptic AMPARs, is activated by the tyrosine-rich motif
of GluA2, and is necessary for both mGluR- and NMDAR-depen-
dent LTD (mGluR- and NMDAR-LTD) in CA1 cell synapses of the
mouse hippocampus. Our results identify AMPAR-mediated
Arf6 activation through BRAG2 as a critical mechanism for tar-
geted synaptic receptor endocytosis that is dynamically regu-
lated by both AMPAR ligand binding and the phosphorylation
state of tyrosine 876 (Y876) in GluA2. This dual-key strategy
provides tight control over the induction of LTD.
RESULTS
AMPARs Directly Interact with BRAG2
Using the C-terminal 36 amino acids of GluA2 as a bait in
a yeast two-hybrid (Y2H) screen through a rat brain cDNA library,
we found two overlapping cDNA clones encoding fragments
of BRAG2 (Someya et al., 2001), a Sec7 domain protein func-
tioning in membrane transport and remodeling (Dunphy et al.,
2006; Morishige et al., 2008; Pajcini et al., 2008). Further Y2H
analyses revealed that BRAG2 bound to all short AMPAR
C-terminal regions (GluA2, GluA3, and GluA4short), but not to
the long C-terminal region of GluA1 (data not shown). Stepwisemutations of GluA2-CT indicated that the interaction did not
require the extreme C terminus, but the tyrosine-rich motif
(ATYKEGYNVY876G, designated 3Y motif) implicated in LTD
(Ahmadian et al., 2004) (Figure 1A). In BRAG2, only fragments
encompassing the Sec7 and PH domains scored positive for
binding to GluA2-CT (Figure 1B). The Sec7-PH regions of
BRAG1, which shows the highest sequence similarity to BRAG2,
or of ARNO, a more distantly related Arf6-GEF of the cytohesin/
GRP1 family, did not bind to GluA2-CT in the Y2H system
(data not shown). These data suggest that short-tailed AMPAR
subunits specifically engage BRAG2 through their 3Y motif.
Glutathione-S-transferase (GST) pull-down assays from lysates
of HEK293 cells stably expressing rat BRAG2 or mouse forebrain
extracts confirmed the physical interaction between BRAG2 and
the 3Y motif of GluA2-CT, and coimmunoprecipitations indi-
cated constitutive complex formation of GluA2 and BRAG2 in
neurons (Figures 1C–1E; for specificity of the two immunoreac-
tive BRAG2 bands, see Figure S3A available online). Moreover,
these experiments revealed a critical role of Y876 in GluA2 for
BRAG2 binding, as GluA2-CT mutants Y876A and V875Y/Y876V
pulled down negligible amounts of BRAG2. However, BRAG2
binding was not affected by mutation Y876F in GluA2-CT.Neuron 66, 768–780, June 10, 2010 ª2010 Elsevier Inc. 769
BRAG2
GluA2
PSD-95
SynPhy
S1H P2 LP
1
LP
1
SP
M
PS
DI
PS
DII
PS
DII
I
10 µg 2 µgC
S1H P1 S2 P2 LS
1
LP
1
LS
2
LP
2
SynPhy
PSD-95
GluA2
BRAG2
B
Arf6
GluA2
-Tubulin
P1E1
8
P7 P1
4
P2
1
P2
8
P4
2A
BRAG2
Figure 2. BRAG2 Is a Component of Mouse Brain Synapses
(A) Expression of BRAG2 in mouse hippocampus during development. E,
embryonic day; P, postnatal day.
(B and C) Distribution of BRAG2 in mouse brain fractions revealing concentra-
tion in synaptic vesicle-enriched (B) and PSD fractions (C). H, homogenate; P1,
crude nuclear fraction; S1, supernatant after P1 precipitation; P2, crude
synaptosomal fraction; S2, supernatant after P2 precipitation; LP1, synapto-
somal membranes (lysate pellet); LS1, crude synaptic vesicle fraction (lysate
supernatant); LP2, synaptic vesicle-enriched fraction; LS2, synaptosomal
cytosol; SPM, synaptosomal plasma membranes; PSD, postsynaptic density
fraction extracted with Triton X-100 once (PSDI), twice (PSDII) or with Triton
X-100 followed by N-lauroyl sarcosine (PSDIII); SynPhy, synaptophysin.
Neuron
AMPARs Directly Trigger BRAG2 Catalysis for LTDThus, the phenyl ring of this tyrosine residue in GluA2 appears to
be crucial for the interaction with BRAG2.
BRAG2 Is a Synaptic Protein
Expression of BRAG2 in the mouse hippocampus is very low at
birth, but gradually increases, similar to GluA2 and Arf6, in
parallel with synaptogenesis (Figure 2A). Upon differential centri-
fugation of adult mouse brain extracts, BRAG2 was detected in770 Neuron 66, 768–780, June 10, 2010 ª2010 Elsevier Inc.a fraction positive for the synaptic vesicle marker synaptophysin
(Figure 2B); in addition, it is highly concentrated in postsynaptic
density (PSD) fractions (Figure 2C), as suggested by previous
mass spectrometry analyses (Jordan et al., 2004; Peng et al.,
2004). Thus, the interaction between AMPARs and BRAG2 can
take place at synapses. BRAG1 and BRAG3 are also enriched
in PSD fractions (Inaba et al., 2004; Murphy et al., 2006), hinting
at a role for the entire BRAG family of Arf6 exchange factors in
synaptic membrane turnover.
AMPARs Directly Stimulate the Exchange Activity
of BRAG2
BRAG2 encompasses an IQ motif, a Sec7, and a PH domain and
functions as a GEF for the small GTPase Arf6 (Someya et al.,
2001). Activation of Arf6 by the catalytic Sec7 domain results in
the recruitment of vesicle coat proteins to the plasma membrane
(D’Souza-Schorey and Chavrier, 2006), but the molecular
mechanisms leading to GEF activation are poorly understood.
The interaction between GluA2 and BRAG2 may provide a link
between a receptor destined for internalization and the initiation
of vesicle formation. Given that the Sec7-PH region of BRAG2 is
involved in binding of GluA2 via GluA2-CT, we tested if this inter-
action might influence the activity of BRAG2 toward Arf6. Indeed,
the bacterially expressed GluA2-CT increased the catalytic
activity of BRAG2 on Arf6 about 5-fold in vitro (Figure 3A) but
was without effect on the exchange rates of BRAG1 and ARNO
(Figure 3B). Thus, the C terminus of GluA2 can trigger Arf6 acti-
vation through interaction with BRAG2.
Tyrosine Phosphorylation of GluA2 Controls
BRAG2 Activity
The GluA2 3Y motif has been shown to be a target for a src
family kinase-dependent phosphorylation in vivo, most likely
at Y876 (Ahmadian et al., 2004; Hayashi and Huganir, 2004).
Neither a V875Y/Y876V- nor a Y876A-mutated construct of
GluA2-CT augmented the exchange rate of BRAG2, whereas
a Y876F-mutated construct of GluA2-CT was fully active (Fig-
ure 3A), in accordance with the effects of these mutations on
the BRAG2 interaction (Figure 1C). Using synthetic peptides
encompassing the 3Y motif with either tyrosine or phospho-
tyrosine at position 876, we found that the unphosphorylated
peptide increased the BRAG2 exchange rate, whereas the
phosphorylated peptide did not (Figure 3C). Phosphatase treat-
ment of the phosphorylated 3Y peptide restored the activity on
BRAG2, demonstrating that the phosphorylation state of Y876
indeed determines the peptide’s effect on the Arf6 exchange
factor activity. We confirmed the regulatory effect of Y876
phosphorylation in the context of the complete intracellular
C-terminal domain (Figure 3D): the increase in the catalytic
activity of the BRAG2 Sec7 domain by GluA2-CT was blocked
by prior in vitro phosphorylation with recombinant src kinase,
whereas the increase mediated by the nonphosphorylatable
Y876F mutant of GluA2-CT was not affected by src. An anti-
phosphotyrosine antibody revealed that under these experi-
mental conditions Y876 was the only amino acid residue
targeted by src (Figure S1). Furthermore, we generated a site-
specific phosphotyrosine antibody and detected src family
kinase-dependent phosphorylation of Y876 in endogenous
200
100
0
)
%(
n
oit
avitc
a
6frA
Sec7-PH
GABA -CTB1
GluA2-CT
Y876A
V875Y/Y876V
Y876F
300
250
200
150
100
50
0
)
%(
n
oit
avitc
a
6frA
Sec7-PH
3Y
3Y(pY876)
control
*
*
*
BRAG2C
0
)
%(
n
oit
avitc
a
6frA
Sec7-PH
GluA2-CT
Y876F
*
* *300
250
200
150
100
50
BRAG2
0
1
2
3
4
5 10 15 200 25 30
)l
o
mp(
d
n
u
ob
S
PT
G
35
Time (min)
ARNO BRAG1
n. s.
n. s.
600
500
400
300
200
100
0
)
%(
n
oit
avitc
a
6frA
Sec7-PH
GABA -CTB1
GluA2-CT
GluA2-CT
Y876F
CIP CIP
srcsrc
srcsrc
600
500
400
300
A
B
BRAG2
D
*
*
Coomassie
Figure 3. The C-Terminal Region of GluA2
Stimulates BRAG2-Mediated Arf6 Activa-
tion In Vitro
(A) GluA2-CT stimulates the GEF activity of
BRAG2 depending on the integrity of the 3Y motif.
Shown are the results of nucleotide exchange
assays (n R 3) using the indicated purified
proteins and Arf6-His in vitro. Bars indicate the
initial reaction rate constants of GTPg35S binding
(a representative experiment is indicated on the
right) normalized to the combination Sec7-PH
and Arf6-His (BRAG2, *p % 0.0001, n = 7).
Sec7-PH, module of the Sec7 and PH domains
of BRAG2; GABAB1-CT, intracellular C-terminal
region of GABAB1; GluA2-CT variants as in
Figure 1C.
(B) GluA2-CT does not stimulate the GEF activities
of ARNO and BRAG1. Bars indicate the initial
reaction rate constants of GTPg35S binding
normalized to the combination Sec7-PH, Arf6-
His, and GABAB1-CT (ARNO, n. s., not significant:
p = 0.053, n = 8; BRAG1, n. s.: p = 0.15, n = 7).
Sec7-PH, modules of the Sec7 and PH domains
of ARNO or BRAG1.
(C) Regulation of BRAG2-mediated Arf6 activation
by 3Y peptides depends on the phosphorylation
state of Y876. BRAG2 stimulation by synthetic
peptides encompassing the tyrosine-rich motif of
GluA2 (3Y) and a Y876-phosphorylated version
thereof (pY876), with or without prior calf intestine
phosphatase (CIP) treatment (*p % 0.005, n = 4).
Control, unrelated peptide.
(D) Regulation of BRAG2-mediated Arf6 activation
by GluA2-CT is blocked by phosphorylation of
Y876. BRAG2 stimulation by GluA2-CT and the
Y876F mutant, with or without prior phosphoryla-
tion by src (*p % 0.0002, n = 6). A phosphoryla-
tion-dependent change in the migration of
GluA2-CT on SDS-PAGE was visualized by Coo-
massie staining.
All data are plotted as mean ± SEM. See also
Figure S1.
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AMPARs Directly Trigger BRAG2 Catalysis for LTDGluA2 (Figure S2), suggesting in vivo relevance of this modifica-
tion. Taken together, these data indicate that the phosphoryla-
tion state of GluA2 Y876 controls the BRAG2-mediated GDP/
GTP exchange on Arf6.
AMPAR Ligand Binding Stimulates BRAG2
We subsequently assayed the Arf6 activity in a cellular environ-
ment. Brief stimulation of HEK293 cells coexpressing GluA2,
BRAG2, and Arf6 with L-glutamate led to increased Arf6 activity,
as assessed by an Arf6GTP-specific pull-down assay (Santy
and Casanova, 2001) (Figure 4A). This effect relied on BRAG2
expression and was prevented by the Y876A mutation in
GluA2, which blocked Arf6 activation by GluA2-CT in vitro. Treat-
ment with the partial AMPAR agonist CNQX, which is unable to
open AMPA channels in absence of TARP auxiliary subunits
(Menuz et al., 2007), also activated Arf6 in this setting (Figure 4B).
Together, these findings confirm the functional connection
between GluA2, BRAG2, and Arf6 and reveal ligand binding toGluA2 as a trigger of BRAG2 catalysis. Occupancy of the gluta-
mate-binding site of AMPARs containing subunits with a 3Y
motif can induce Arf6 activation by BRAG2, presumably inde-
pendent of current flow.
Determinants Underlying Activation of Synaptic Arf6
Next, we monitored the activity of endogenous Arf6 in cultured
hippocampal neurons. Our experiments with recombinant pro-
teins suggested that both ligand binding and tyrosine phosphor-
ylation may regulate Arf6 activation by AMPARs in concert. A 15
min treatment with picrotoxin to increase neuronal activity
resulted in a slight increase in Arf6GTP (Figure 4C). Inhibition of
src family tyrosine kinases by PP2, which prevented phosphory-
lation at Y876 of GluA2 (Figure S2C), activated neuronal Arf6 as
well. However, a particularly strong Arf6 activation was observed
upon combined treatment with PP2 and picrotoxin. Thus,
neuronal Arf6 activity appears to be held in check by src family
tyrosine kinases.Neuron 66, 768–780, June 10, 2010 ª2010 Elsevier Inc. 771
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Figure 4. AMPAR Ligand Binding Stimulates BRAG2-Mediated Arf6 Activation
(A) L-glutamate-triggered BRAG2 stimulation. Shown are representative immunoblots of Arf6GTP-specific pull-down assays (n R 9) from HEK293 and HEK-
BRAG2 cells expressing Arf6-HA and either HA-tagged GluA2 or GluA2-Y876A. Bars illustrate Arf6 activation calculated as the Arf6GTP/Arf6total ratio (pd/t) of cells
treated with L-glutamate (*p = 0.001, n = 15) normalized to untreated controls.
(B) CNQX-triggered BRAG2 stimulation. Shown is a representative immunoblot of Arf6GTP-specific pull-down assays (n = 10) from HEK-BRAG2 cells expressing
Arf6-HA and HA-tagged GluA2. Bars illustrate Arf6 activation calculated as the Arf6GTP/Arf6total ratio (pd/t) of cells treated with CNQX (*p = 0.01, n = 10) normalized
to untreated controls.
(C) Activation of endogenous Arf6 is regulated by src family tyrosine kinases and neuronal activity. Shown are representative immunoblots of Arf6GTP-specific
pull-down assays from cultured hippocampal neurons pretreated with src family kinase inhibitor PP2 or its inactive structural analog PP3 and stimulated with
picrotoxin (PiTX). The bar graphs illustrate Arf6 activation by PP3/PiTX (*p = 0.048), PP2 (*p = 0.006), and PP2/PiTX (*p = 0.00006) as the Arf6GTP/Arf6total ratio
(pd/t) normalized to PP3-treated controls (n = 15). pd, pull-down; t, total.
All data are plotted as mean ± SEM.
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AMPARs Directly Trigger BRAG2 Catalysis for LTDmGluR-Triggered Dephosphorylation of GluA2 Y876
The findings described so far are consistent with an important
role of GluA2 Y876 phosphorylation in regulating synaptic
Arf6 activity. A major form of Schaffer collateral LTD, mGluR-
LTD, relies on tyrosine phosphatase activity and is accompa-
nied by tyrosine dephosphorylation of GluA2 (Gladding et al.,
2009; Huang and Hsu, 2006; Moult et al., 2006, 2008), but
the exact tyrosine residue has not been determined. We
therefore monitored mGluR-dependent changes in the phos-
phorylation level at Y876 in GluA2 using anti-pY876 (Fig-
ure S2) in neuronal cultures. An increase of the neuronal
activity by picrotoxin, as frequently applied in mGluR-LTD
experiments (Palmer et al., 1997), augmented phosphorylation
of this site (Figure 5A), presumably through increased gluta-
mate release and AMPAR ligand binding (Hayashi and Huganir,
2004; Hayashi et al., 1999). Importantly, additional applica-
tion of DHPG, a selective agonist of group I mGluRs, strongly
reduced pY876 (Figure 5B). These results directly show that
phosphorylation of Y876, which was critical for BRAG2 stim-
ulation in vitro (Figures 3C and 3D), dynamically responds to
synaptic activity and mGluR engagement. Given the high
sequence similarity between the 3Y motif of short-tailed
AMPA receptor subunits (Figure 1A), we cannot completely
rule out that GluA3 or GluA4short contribute to signals detected
by anti-pY876, provided they are phosphorylated at the
homologous residue. Nonetheless, our data identify Y876 as
a residue in GluA2 targeted by a tyrosine phosphatase during
mGluR-LTD.772 Neuron 66, 768–780, June 10, 2010 ª2010 Elsevier Inc.BRAG2 Mediates mGluR-Induced Arf6 Activation
We went on analyzing the nucleotide-binding state of Arf6
following mGluR activation. Short treatment with DHPG trig-
gered an increase in the amount of active Arf6, reminiscent of
the PP2 effect (Figures 5C and 4C). Combined application
revealed that the effects of DHPG and PP2 were not additive,
but occlusive. The two independent tyrosine phosphatase inhib-
itors sodium orthovanadate (OV) and phenylarsine oxide (PAO),
which prevent mGluR-LTD (Moult et al., 2006), blocked the
DHPG effect without affecting basal Arf6 activation, indicating
that tyrosine dephosphorylation is necessary for DHPG-induced
Arf6 activation in cultured neurons. In conjunction with our find-
ings with recombinant proteins (Figure 3) and our analysis
employing anti-pY876 (Figure 5B), the above data are consistent
with the hypothesis that DHPG-triggered Arf6 activation is medi-
ated by dephosphorylation of Y876 in GluA2 and subsequent
BRAG2 stimulation. Indeed, suppression of BRAG2 expression
by RNA interference (RNAi) with lentivirally delivered short-
hairpin RNAs (Figure S3A) prevented the DHPG effect (Fig-
ure 5D). Therefore, BRAG2 is required for Arf6 activation
following DHPG stimulation.
BRAG2-Mediated Arf6 Activation Is an Essential Step
in mGluR-Induced AMPAR Internalization
Expression of mGluR-LTD, like several other forms of LTD, relies
on regulated endocytosis, resulting in a persistent decrease of
surface AMPARs. Since Arf6 is a well-known regulator of endo-
cytic transport at the cell surface, we assessed whether BRAG2
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Figure 5. mGluRs Trigger Dephosphorylation of GluA2 Y876 and BRAG2-Mediated Arf6 Activation
(A) Phosphorylation of GluA2 Y876 in cultured hippocampal neurons upon picrotoxin (PiTX) treatment. The bars show pY876/GluA2-ratios of GluA2 immunopre-
cipitates from neurons treated with PiTX normalized to unstimulated controls (*p = 0.033, n = 5), Top: representative immunoblot.
(B) Dephosphorylation of GluA2 Y876 upon DHPG treatment. The bars show pY876/GluA2 ratios of GluA2 immunoprecipitates from neurons treated with PiTX/
DHPG normalized to PiTX-treated controls (*p = 0.007, n = 5). Top: representative immunoblot.
(C) DHPG stimulates Arf6 activation in cultured neurons depending on tyrosine phosphatase activity. Shown are results of Arf6GTP-specific pull-down assays from
3- to 4-week-old cultured hippocampal neurons, pretreated or not with the src family kinase inhibitor PP2 or tyrosine phosphatase inhibitors (OV, PAO), and
stimulated with DHPG. Arf6 activation by DHPG was calculated as the Arf6GTP/Arf6total ratio (pd/t) normalized to the respective control without DHPG
(*p = 0.008, n = 6). Basal Arf6 activation was selectively increased by PP2 (123% ± 8% of control, p = 0.02, n = 5). Top: representative immunoblots. pd,
pull-down; t, total.
(D) DHPG-stimulated Arf6 activation is prevented by RNAi to BRAG2. Cultured hippocampal neurons infected with lentiviruses delivering RNAi to BRAG2 (RNAi1,
RNAi2) or a control hairpin (RNAictrl) were treated with or without DHPG. The bar graphs illustrate DHPG-stimulated Arf6 activation calculated as in (C)
(*p = 0.0008, n = 9). Top: representative immunoblots.
All data are plotted as mean ± SEM. See also Figures S2 and S3.
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AMPARs Directly Trigger BRAG2 Catalysis for LTDalso played a role in the sustained decrease of surface AMPARs
after DHPG treatment of neurons (Snyder et al., 2001). Two inde-
pendent assays for monitoring the surface expression of GluA2
yielded the same result: the reduction of surface-expressed
GluA2 by DHPG was prevented by knockdown of BRAG2
(Figures 6A and 6B). We conclude that BRAG2 is not only essen-
tial for Arf6 activation, but also for the long-term reduction of
surface AMPARs induced via mGluRs. Expression of a catalyti-
cally inactive form of BRAG2 (Figures S3B and S3C) or of an
Arf6 mutant incapable of GTP binding (Macia et al., 2004)
blocked the DHPG-induced reduction of surface GluA2 as well,
confirming the critical role of BRAG2-mediated Arf6 activation
in this signal transduction pathway (Figures 6C and 6D). More-
over, the surface reduction of GluA2 upon DHPG treatment
was prevented by the competitive AMPAR antagonist NBQX
(Figure 6E), indicating a requirement for agonist-dependent
AMPAR signaling to BRAG2 (Figure 4A and 4B). An increased
rate of endocytosis contributes to the persistent reduction of
surface AMPARs induced by mGluRs (Gladding et al., 2009;
Waung et al., 2008). We therefore directly assessed the mGluR-
induced GluA2 internalization and found that it strictly depends
on the catalytic activity of BRAG2 (Figure 6F). None of the manip-
ulations of BRAG2, neither knockdown nor expression of
recombinant BRAG2 constructs, affected the basal amount of
surface GluA2 (Figure S3D). Together, BRAG2 appears to trans-
late ligand binding and tyrosine dephosphorylation of GluA2 into
Arf6 activation for mGluR-controlled endocytosis of AMPARs.mGluR-LTD in Hippocampal CA1 Neurons Depends
on BRAG2
We next applied lentiviral BRAG2-RNAi to the hippocampal CA1
region by stereotaxic injection in 3-week-old mice and assessed
mGluR-LTD in acute hippocampal slices 2 weeks after viral infec-
tion. Excitatory postsynaptic currents (EPSCs) in RNAi-infected,
mock-infected, and noninfected CA1 pyramidal neurons were
comparable before DHPG perfusion. DHPG strongly depressed
EPSCs within 10 min by about 70% in all three groups (Figure 7A).
During DHPG washout, neurons from mock-infected and nonin-
fected neurons partially recovered to about 60% of control, and
LTD became apparent in both groups. In contrast, EPSCs in
RNAi-infected neurons steadily recovered, reaching baseline
40 min after terminating DHPG perfusion. 30 min after terminating
DHPG perfusion, RNAi-infected neurons (87.3% ± 4.3%, n = 11
neurons, 9 mice) significantly differed from mock-infected
(57.5% ± 6.8%, n = 7 neurons, 4 mice; p = 0.002) and noninfected
neurons (60.5% ± 5.0%, n = 9 neurons, 7 mice; p = 0.0004). Thus,
knockdown of BRAG2 prevented the expression of LTD but did
not interfere with the initial DHPG effects, which also occur in
the presence of endocytosis inhibitors (Xiao et al., 2001).
In addition, we generated mice in which loxP sites flank the
essential exon 2 of the BRAG2 gene Iqsec1 (Iqsec1fl/fl), thus per-
mitting Cre-mediated deletion of the gene (Figures S4A and S4C).
BRAG2 expression did not differ between wild-type and Iqsec1fl/fl
mice (Figure S4B). We injected a lentiviral vector expressing Cre
recombinase and EGFP into the hippocampal CA1 region ofNeuron 66, 768–780, June 10, 2010 ª2010 Elsevier Inc. 773
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Figure 6. AMPAR-BRAG2 Signaling to Arf6
Is Necessary for mGluR-Induced Internali-
zation of AMPARs
(A) DHPG-triggered long-term reduction of surface
GluA2 is mediated by BRAG2. Cultured hippo-
campal neurons infected with lentiviruses deliv-
ering RNAi to BRAG2 as described in Figure 5D
were treated with or without DHPG and analyzed
for both total and surface GluA2 expression using
a cell ELISA. The bars depict the GluA2 total (t) and
surface (sf) expression of neurons 55 min after
terminating DHPG treatment (5 min) normalized
to the respective untreated controls (n R 6).
DHPG treatment resulted in a selective reduction
of surface GluA2 (*p = 0.00003, n = 12), and this
effect was blocked by RNAi to BRAG2 (RNAi1,
p = 0.31, n = 6; RNAi2, p = 0.28, n = 6). ALU, arbi-
trary light units.
(B) Neurons were infected and stimulated as in (A),
but total and surface levels of endogenous GluA2
were quantified using a surface biotinylation
assay. The bars depict the GluA2 surface/total
ratios (sf/t) of neurons 1 hr after treatment with
DHPG normalized to the respective untreated
controls. DHPG treatment resulted in a selec-
tive reduction of the GluA2 surface expression
(*p = 0.005, n = 8), and this effect was blocked
by RNAi to BRAG2 (RNAi1, p = 0.48, n = 8;
RNAi2, p = 0.41, n = 8). Representative immuno-
blots to GluA2 and Cadherin are shown on the left.
(C) DHPG-triggered long-term removal of surface
GluA2 relies on the catalytic activity of BRAG2.
Neurons infected with lentiviruses for expression
of BRAG2-EGFP (BRAG2) or a catalytically inac-
tive mutant (E604K) were stimulated and analyzed
as in (B). DHPG treatment resulted in a selective
reduction of GluA2 surface levels in neurons ex-
pressing BRAG2 (*p = 0.034, n = 9), and this effect
was blocked upon expression of the E604K mutant
(p = 0.28, n = 13). Representative immunoblots to
GluA2 and Cadherin are shown on top. A compar-
ison between the expression of BRAG2 and E604K
is shown beneath the bar graphs.
(D) DHPG-triggered long-term removal of surface GluA2 requires active Arf6. Neurons infected with lentiviruses for expression of Arf6-HA (Arf6) or a constitutively
inactive mutant (T44N) were treated and analyzed as in (B). DHPG treatment resulted in a selective reduction of GluA2 surface expression in neurons expressing
Arf6 (*p = 0.002, n = 5), and this effect was blocked by expression of Arf6-T44N (p = 0.46, n = 5). Representative immunoblots to GluA2 and Cadherin are shown on
top. Expression of HA-tagged Arf6 and Arf6-T44N as compared to endogenous Arf6 (lower bands) is shown beneath the bar graphs.
(E) AMPA receptor ligand binding is necessary for DHPG-triggered long-term removal of surface GluA2. Uninfected neurons were stimulated with DHPG for 5 min
and incubated for 55 min, in absence or sustained presence of the AMPA receptor antagonist NBQX. Surface and total amounts of GluA2 and Cadherin were
analyzed as in (B). DHPG treatment resulted in a selective reduction of GluA2 surface expression in absence of NBQX (*p = 0.001, n = 9), and this effect was
blocked by NBQX (p = 0.24, n = 9). Representative immunoblots to GluA2 and Cadherin are shown on top.
(F) BRAG2-mediated Arf6 activation is necessary for DHPG-induced endocytosis of GluA2. Neurons infected as in (C) were analyzed for DHPG-triggered endo-
cytosis of GluA2 using reversible surface biotinylation. The bars depict the amount of GluA2 internalized within 10 min upon DHPG treatment as the percentage of
basal internalization. Background levels of GluA2 without internalization (0 min) were subtracted from all values. Internalization of GluA2 was significantly
increased in DHPG-treated cultures expressing BRAG2 (*p = 0.01, n = 9), and this effect was blocked upon expression of catalytically inactive mutant E604K
(p = 0.34, n = 9). Strip, removal of biotin from the cell surface.
All data are plotted as mean ± SEM. See also Figure S3.
Neuron
AMPARs Directly Trigger BRAG2 Catalysis for LTD3-week-old Iqsec1fl/fl mice and investigated mGluR-LTD 2 weeks
later (Figure 7B). The DHPG response of CA1 neurons having
undergone Cre-mediated deletion of BRAG2 was similar to the
response recorded after RNAi-mediated knockdown of BRAG2.
In the absence of BRAG2, the currents recovered to baseline
within 30 min after DHPG perfusion (101.2% ± 5.1%, n = 8
neurons, 5 mice), whereas LTD was induced in noninfected774 Neuron 66, 768–780, June 10, 2010 ª2010 Elsevier Inc.neurons (60.8% ± 4.4%, n = 7 neurons, 5 mice; p = 0.00002
between groups). Collectively, our results clearly show that
BRAG2 is essential for hippocampal mGluR-LTD.
BRAG2 Binding to GluA2 Is Necessary for mGluR-LTD
To examine whether the interaction of BRAG2 with GluA2 is crit-
ical for mGluR-LTD, we employed peptide competition. Peptides
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Figure 7. BRAG2 and AMPAR Ligand
Binding Are Necessary for mGluR-LTD of
Schaffer Collateral Synapses
(A) Cell-specific knockdown of BRAG2 blocks
mGluR-LTD at hippocampal CA3-CA1 synapses.
Acute slices of in vivo-infected mice (surgery at
P21; electrophysiology 2 weeks later) were treated
with DHPG, which induced mGluR-LTD in control
CA1 neurons (noninfected or mock-infected), but
not in neurons infected with lentiviruses delivering
shRNAs against BRAG2 (RNAi).
(B) Deletion of BRAG2 in single CA1 neurons
blocks mGluR-LTD. Experiments performed as
described in (A), except that Cre-expressing lenti-
viruses were injected into mice homozygous for
a floxed BRAG2 allele (Iqsec1fl/fl). Results for cre-
infected (DBRAG2) and noninfected (control)
neurons are shown.
(C) Acute blockade of the interaction between
GluA2 and BRAG2 prevents mGluR-LTD. Shown
are mGluR-LTD analyses in hippocampal slices
of wild-type mice with a recombinant GST fusion
protein containing the 3Y sequence YKEGYNVYGI
(GST-3Y), or a control with a single amino acid per-
mutation, reading YKEGYNYVGI [GST-3Y(V875Y/
Y876V)], back-filled into the patch pipette at
100 mg/ml prior to DHPG perfusion.
(D and E) mGluR-LTD requires AMPAR ligand
binding. CA1 neurons in hippocampal slices of
wild-type mice were stimulated by two indepen-
dent pathways (test and control pathway). Inter-
ruption of stimulation in the test pathway during
and following DHPG perfusion (35 min) prevented
mGluR-LTD induction (D). Presence of the broad-
spectrum ionotropic glutamate receptor antago-
nist kynurenic acid (Kyn) prevented mGluR-LTD
induction by DHPG in wild-type mice (E).
(A–E) Six consecutive traces were averaged at
time points marked by numbers in the respective
time course. Scale bars: 50 pA, 20 ms. All data
points are plotted as mean ± SEM. See also
Figures S3 and S4.
Neuron
AMPARs Directly Trigger BRAG2 Catalysis for LTDwith the 3Y motif of GluA2 interfere with LTD induced by different
protocols (Ahmadian et al., 2004; Brebner et al., 2005; Fox et al.,
2007; Yu et al., 2008), but mGluR-LTD has not been assessed.
We found that inclusion of the active 3Y peptide fused to GST
(GST-3Y) in the patch pipette blocked mGluR-LTD expression
in CA1 neurons from 5-week-old wild-type mice with the sameNeuron 66, 768–7time course as observed in neurons
infected with either BRAG2-RNAi in
wild-type or with Cre in Iqsec1fl/fl mice
(Figure 7C). In contrast, GST fused to
a 3Y peptide with the V875Y/Y876V per-
mutation [GST-3Y(V875Y/Y876V)] that
abrogates binding to BRAG2 (Figure 1C)
remained inactive. 30 min after termi-
nating DHPG perfusion, GST-3Y-infused
neurons (88.31% ± 4.2%, n = 7 neurons,
5 mice) were significantly different from
GST-3Y(V875Y/Y876V)-infused neurons(53.0% ± 7.2%, n = 6 neurons, 4 mice; p = 0.001). These exper-
iments indicate that the relevant effect of the active 3Y peptide is
interference with BRAG2 binding. The match between the results
of chronic BRAG2 ablation and acute peptide competition
further corroborates the functional link between the 3Y motif of
GluA2 and BRAG2.80, June 10, 2010 ª2010 Elsevier Inc. 775
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Figure 8. NMDAR-LTD Is Mediated by
BRAG2
(A) Deletion of BRAG2 in single CA1 neurons
blocks NMDAR-LTD. Low-frequency (2.5 Hz) stim-
ulation of Schaffer collaterals for 6 min in presence
of mGluR antagonists BAY 36-7620 and MPEP-
HCl induced LTD in noninfected (control) but not
in Cre virus-infected (DBRAG2) CA1 neurons of
P35 Iqsec1fl/fl mice.
(B) NMDAR-LTD is independent of tyrosine
dephosphorylation. NMDAR-LTD (control) was not
altered in the presence of tyrosine phosphatase
inhibitors (PAO, OV) but was inhibited in the pres-
ence of an NMDA receptor antagonist (APV) in CA1
neurons of wild-type mice.
(A and B) For details regarding traces, scale bars,
and data points, see Figure 7.
See also Figure S4.
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AMPARs Directly Trigger BRAG2 Catalysis for LTDAMPAR Ligand Binding Is Necessary for mGluR-LTD
Experiments in HEK293 cells showed increased BRAG2-depen-
dent Arf6 activation in the presence of AMPAR ligands (Figures
4A and 4B) and the competitive AMPAR antagonist NBQX
blocked the DHPG-induced persistent reduction of surface
AMPARs in dissociated neurons (Figure 6E). To test whether
glutamate binding to AMPARs is necessary for mGluR-LTD in
the hippocampus, we stimulated two independent pathways in
stratum radiatum before DHPG perfusion. Stimulation was
stopped in one pathway during and 25 min following DHPG
perfusion and then resumed for 15 min, whereas stimulation pro-
ceeded in the second pathway. If ligand binding to AMPARs is
necessary for mGluR-LTD, interruption of stimulation should
prevent its expression. Indeed, mGluR-LTD was not induced in
the pathway with interrupted stimulation, whereas mGluR-LTD
was induced in the second pathway (Figure 7D). Compared to
baseline, EPSCs were only reduced in the stimulated path-
way 35 min after terminating DHPG perfusion (58.9% ± 5.2%,
p = 0.005 versus 94.7% ± 9.5%, p = 0.3; n = 11 neurons,
5 mice). To corroborate this finding, we activated mGluRs while
ionotropic glutamate receptors were antagonized by kynurenic
acid (Kyn, 2 mM) (Figure 7E). Following washout of Kyn, EPSCs
recovered to baseline within 30 min, indicating that DHPG did
not induce LTD under these conditions (101.5% ± 8.6%,
p = 0.4; n = 8 neurons, 4 mice). EPSCs similarly (p = 0.4) recov-
ered when Kyn was perfused alone (98.9% ± 13.3%, p = 0.4;
n = 4 neurons, 3 mice). These results substantiate a critical role
for AMPAR ligand binding in mGluR-LTD.
Both mGluR- and NMDAR-LTD Rely on BRAG2
So far, our data revealed the importance of the interaction
between the 3Y motif in GluA2 and BRAG2 for mGluR-LTD.
However, the effect of 3Y peptides on LTD induced through776 Neuron 66, 768–780, June 10, 2010 ª2010 Elsevier Inc.different pathways indicates a general
requirement of interactions mediated by
this motif for LTD expression. We there-
fore asked if BRAG2 was also involved
in NMDAR-LTD using the cell-specific
Cre-mediated BRAG2 deletion strategydescribed above (Figure 8A). Low-frequency stimulation (LFS)
of the Schaffer collaterals in the presence of mGluR antagonists
induced LTD in noninfected (46.7% ± 2.5%, n = 5 neurons,
3 mice) but not Cre-infected neurons of Iqsec1fl/fl mice (91.1% ±
4.6%, n = 4 neurons, 3 mice; p = 0.0002 between groups).
This LFS-induced LTD (LFS-LTD) was blocked by the NMDAR
antagonist D-APV (50 mM) (Figure 8B; 90.9% ± 5.1%, n = 6
neurons, 4 mice; p = 0.3 compared to baseline). Thus, expres-
sion of BRAG2 in CA1 neurons is necessary for both mGluR-
and NMDAR-LTD of Schaffer collateral projections. Chemically
induced NMDAR-LTD was shown to be independent of tyrosine
dephosphorylation (Moult et al., 2006). In accord, the tyrosine
phosphatase inhibitor OV (1 mM) or PAO (15 mM) did not affect
NMDAR-LTD induced by LFS (control: 48.1% ± 6.7%, n = 6 neu-
rons, 5 mice; OV: 49.7% ± 8.4%, n = 6 neurons, 3 mice, p = 0.4;
PAO: 38.8% ± 7.8%, n = 5 neurons, 3 mice, p = 0.2). We conclude
that diverse pathways stimulating clathrin-mediated AMPAR
endocytosis converge on GluA2-associated BRAG2.
DISCUSSION
LTD is a modification in synaptic strength involved in learning
events in various brain areas (Massey and Bashir, 2007). Here
we show that the Arf6-GEF BRAG2 is essential for hippocampal
LTD. Depending on the phosphorylation state of Y876 in GluA2,
BRAG2 translates AMPAR ligand binding into Arf6 activation,
which in turn triggers AMPAR internalization for persistent
synaptic depression. Thus, AMPARs control their own removal
from the synapse through BRAG2.
As holds true for the other two members of the BRAG family
(Inaba et al., 2004; Murphy et al., 2006), we found BRAG2
to be concentrated in PSD fractions and to resist detergent
extraction, indicative of core elements of this postsynaptic
Neuron
AMPARs Directly Trigger BRAG2 Catalysis for LTDspecialization. Therefore, it seems likely that BRAG2 binds and
affects primarily synaptic AMPARs. GluA2 and BRAG2 could
be coimmunoprecipitated from cultured neurons independent
of LTD-inducing stimuli, suggesting that a significant fraction of
AMPARs interacts constitutively with BRAG2.
GEF Activity of BRAG2 Controlled by Protein-Protein
Interaction
The binding of the tyrosine-rich sequence motif of AMPARs to
the Sec7-PH module of BRAG2 resulted in a strong augmenta-
tion of the catalytic activity of BRAG2. This is a surprising new
feature in Arf-GEF regulation, given that in the closely examined
Arf6-GEFs of the cytohesin/Grp1 family, which also contain
a Sec7-PH tandem, binding of specific phosphatidylinositol
phosphate species to the PH domain enhances the exchange
activity of the catalytic Sec7 domain (Chardin et al., 1996;
Klarlund et al., 1997). In stark contrast, the catalytic activity of
BRAG2 is unaffected by phospholipids, and the PH domain of
BRAG2 shows a low degree of conservation compared to the
one of cytohesins, which suggested distinct binding partners
of these two Arf6-GEF families (Someya et al., 2001). Recently,
the PH domain of BRAG2 was shown to interact with the phos-
phorylated C terminus of the EGF receptor (Morishige et al.,
2008). Together with our data, this suggests that the PH domain
of BRAG2 may have evolved to sense intracellular domains of
surface receptors instead of plasma membrane lipid modifica-
tions for regulation of the Sec7 activity. Based on their conserva-
tion, the PH domains of the other BRAG family members are
likely to mediate a similar function for different membrane
proteins.
Determinants of AMPAR-Associated BRAG2 Activity
Our data reveal that the activation of BRAG2 by AMPARs is
tightly regulated. We provide evidence that ligand binding to
GluA2 in heterologous cells stimulates BRAG2 and that an
increase in the synaptic activity of neuronal cultures leads to
Arf6 activation, particularly if tyrosine phosphorylation is phar-
macologically inhibited. These data indicate that ligand binding
to unphosphorylated AMPARs can trigger BRAG2 catalysis.
Consistently, mGluR-LTD in hippocampal slices required not
only BRAG2 but also persistent synaptic activity. The latter
requirement was not found for mGluR-LTD induced under exper-
imental conditions allowing postsynaptic depolarizations and/or
involving presynaptic expression mechanisms (Fitzjohn et al.,
2001; Huber et al., 2001). However, we confirmed that AMPAR
activation is crucial, since both induction of mGluR-LTD in slices
and DHPG-induced reduction in surface GluA2 in neuronal
cultures were prevented by application of ionotropic glutamate
receptor antagonists. Thus, we conclude that AMPAR ligand
binding triggers, besides channel opening, signal transduction
through the intracellular C-terminal region regulating endocytic
traffic. The details of how occupancy of the glutamate-binding
site translates into conformational changes at the C-tail of
GluA2 for BRAG2 activation remain to be determined.
In addition, BRAG2 stimulation is controlled by phosphoryla-
tion of Y876 in GluA2. Our data reveal that phosphorylation of
this tyrosine residue interferes with the signal transduction
from GluA2 to BRAG2. Glutamate receptor agonist treatmentcauses tyrosine phosphorylation of GluA2 (Hayashi and Huganir,
2004), and we show that increased synaptic activity actually
induces phosphorylation of GluA2 Y876. Thus, it appears that
AMPAR-BRAG2 signaling is precluded during basal synaptic
transmission by phosphorylation at Y876 in GluA2. Interestingly,
a mutant of GluA2 that cannot be phosphorylated at the relevant
position (Y876F) showed reduced clustering, surface expres-
sion, and synaptic localization as compared to the wild-type
subunit (Hayashi and Huganir, 2004). Hence, phosphorylation
of GluA2 Y876 may stabilize AMPARs at active synapses by pro-
tecting AMPARs from ligand-induced BRAG2 stimulation and
internalization.
A series of conclusive experiments established that a tyrosine
phosphatase activity is necessary for induction of mGluR-LTD
(Huang and Hsu, 2006; Moult et al., 2006, 2008) and that tyrosine
dephosphorylation of GluA2 occurs transiently at cell surface
AMPARs during mGluR-LTD (Gladding et al., 2009; Huang and
Hsu, 2006; Moult et al., 2006). Our data reveal that the combina-
tion of AMPAR ligand binding and dephosphorylation of GluA2
Y876 triggers BRAG2-mediated Arf6 activation during mGluR-
LTD. Thus, a dual key strategy ensures that ligand-engaged
AMPARs enter into the endocytic route only during LTD.
A Converging Step in mGluR- and NMDAR-LTD
We found that BRAG2 is required at hippocampal synapses not
only for mGluR-LTD but also for NMDAR-LTD, which differ
considerably in their molecular mechanisms and do not occlude
each other (Nicoll et al., 1998; Oliet et al., 1997). This result indi-
cates that the GluA2-BRAG2 interaction constitutes a crucial
requirement for regulated synaptic depression in general,
considering that the previously published effects of the GluA2
3Y peptides on LTD (Ahmadian et al., 2004; Brebner et al.,
2005; Fox et al., 2007; Van den Oever et al., 2008; Yu et al.,
2008) rely on competition with BRAG2 binding. It is therefore
tempting to speculate that NMDAR-LTD also requires BRAG2
stimulation triggered by AMPARs with GluA2 Y876 in the
unphosphorylated state. However, while NMDAR-LTD has been
shown to rely on dephosphorylation of serine 845 in GluA1 (Lee
et al., 2003, 2010), unlike mGluR-LTD it does not require acute
tyrosine dephosphorylation (Moult et al., 2006) (Figure 8B).
It remains to be resolved how GluA2-associated BRAG2 is
activated independently of tyrosine phosphatase activity. The
simplest scenario may be that NMDAR-LTD compromises
ligand-binding-dependent phosphorylation of Y876 in GluA2,
although NMDA treatment of hippocampal slices did not sig-
nificantly reduce the overall AMPAR tyrosine phosphorylation
state (Gladding et al., 2009). Alternatively, during NMDAR-LTD,
BRAG2 activity may be regulated through Ca2+/calmodulin inter-
actions with the IQ motif (but see Someya et al. [2001]) or through
serine/threonine phosphorylation of BRAG2 (Munton et al.,
2007).
LFS induced NMDAR-LTD in Schaffer collaterals of young
GluA2A3 knockout mice (Meng et al., 2003), and cultured hippo-
campal neurons derived from these mice showed NMDA-depen-
dent, clathrin-mediated AMPAR endocytosis (Biou et al., 2008).
These data clearly show that regulated AMPAR endocytosis
can occur independently of the AMPAR-BRAG2 link. However,
in the light of the large body of evidence supporting the role ofNeuron 66, 768–780, June 10, 2010 ª2010 Elsevier Inc. 777
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AMPARs Directly Trigger BRAG2 Catalysis for LTDGluA2 in LTD (Kessels and Malinow, 2009; Malenka and Bear,
2004; Shepherd and Huganir, 2007), the targeted deletion of
GluA2A3 most likely resulted in a modified LTD mechanism
that is normally not expressed in CA1 neurons. The synaptic tar-
geting of homomeric GluA1 receptors, which mediate the EPSCs
in CA1 neurons lacking GluA2 and GluA3, is severely compro-
mised (Lu et al., 2009). The altered subunit composition has
consequences for the equilibrium between synaptic and extrasy-
naptic AMPARs and may also affect their lateral membrane
diffusion and endocytic traffic. Indeed, LTD was less sensitive
to blockade of endocytosis in GluA2A3 knockout than in wild-
type mice (Meng et al., 2003). In mature wild-type CA1 neurons,
all synaptic AMPARs contain the GluA2 subunit (Lu et al., 2009),
allowing AMPAR endocytosis for NMDAR- and mGluR-LTD to be
controlled by the interaction between GluA2 and BRAG2.
Role of Arf6 in LTD
Our data identifyBRAG2-mediated Arf6 activation asa critical step
in DHPG-induced AMPAR endocytosis and in LTD, raising the
question of the direct function of activated Arf6 at the synapse.
Arf6 plays a role in actin and membrane remodeling (D’Souza-
Schorey and Chavrier, 2006), processes that are intimately
involved in the modulation of excitatory synapses. The localized
activation of Arf6 may trigger changes in the actin cytoskeleton,
which not only are crucial for regulated AMPAR trafficking but
also underlie morphological plasticity of dendritic spines (Derkach
et al., 2007). In fact, BRAG2-mediated Arf6 activation has been
shown tobe important for structural changes of cell-to-cell contact
sites, mediating processes of myotube fusion and cancer invasion
(Morishige et al., 2008; Pajcini et al., 2008), and Arf6 is involved in
the development of dendritic spines (Choi et al., 2006). It is there-
fore conceivable that upon LTD induction the AMPAR-induced
Arf6 activation through BRAG2 links the reduction in surface
receptor levels to changes in spine morphology, thus balancing
efficacy and structure of the postsynaptic specialization.
Importantly, however, Arf6 activation also contributes directly
to the formation of clathrin-coated vesicles at the plasma mem-
brane. It does so by triggering a local increase in phosphatidyl-
inositol (4,5)-bisphosphate [PtdIns(4,5)P2], which mediates the
initial contact of the clathrin adaptor complex AP2 with the
plasma membrane (Krauss et al., 2003), and by direct interaction
of AP2 with GTP-bound Arf6 (Paleotti et al., 2005). Moreover,
AP2 can directly bind to GluA2-CT (Kastning et al., 2007;
Lee et al., 2002), and a combination of PtdIns(4,5)P2 and of
binding sites for AP2 on the endocytic cargo protein is thought
to be necessary for efficient recruitment of the AP2 complex to
the plasma membrane (Di Paolo and De Camilli, 2006). Local
Arf6 activation by the 3Y motif of GluA2 may therefore promote
direct binding of AP2 to GluA2-CT for the formation of AMPAR-
containing clathrin-coated pits during LTD. Activated Arf6 may
also endow nascent coats with a special protein composition
that determines the dynamics and destinations of the resulting
endocytic vesicles (Puthenveedu and von Zastrow, 2006). In
addition, LTD likely adjusts intracellular sorting of AMPARs into
recycling and/or degradation pathways, and Arf6 may play
a part here as well.
It is a general question how a receptor to be internalized is
coupled to the activation of Arf6 (Paleotti et al., 2005). The direct778 Neuron 66, 768–780, June 10, 2010 ª2010 Elsevier Inc.cooperation between cargo and Arf6-GEF, which we identified
here, ensures tight spatial and temporal control over Arf6-medi-
ated coat recruitment. Cargo-mediated stimulation of selected
Sec7-domain-containing exchange factors may therefore con-
stitute a widespread cellular mechanism for initiating targeted
membrane transport.
EXPERIMENTAL PROCEDURES
Information on reagents, DNA constructs, cell culture, and biochemistry as
well as further details of the procedures mentioned below are provided in
the Supplemental Information.
Nucleotide Exchange Assay
Arf6 was expressed as described before (Randazzo and Fales, 2002) and myr-
istoylated using plasmid pBB131 (Duronio et al., 1990), which was provided by
Dr. Jeffrey Gordon. Nucleotide exchange on Arf6 in vitro was assayed as
described (Someya et al., 2001; Venkateswarlu, 2003).
Cellular Arf6-Activation Assay
Arf6 activation in HEK293 cells and cultured rat hippocampal neurons was
determined using an Arf6GTP-specific pull-down assay (Santy and Casanova,
2001). Immunoblots were quantified using a ChemiDoc RS170 densitometer
and Quantity One 4.2 software (Biorad).
Lentiviral Expression
FUGW-based vectors (Dittgen et al., 2004; Lois et al., 2002) for lentiviral
expression of short-hairpin RNA constructs and cre recombinase were gener-
ated using plasmids provided by Dr. Carlos Lois and Dr. Pavel Osten.
Iqsec1fl/fl Mice
Gene targeting in embryonic stem cells (Nagy et al., 1993) was used to intro-
duce loxP sites flanking exon 2 of the BRAG2 gene Iqsec1.
In Vivo Infection of Hippocampal Neurons and Electrophysiology
All animal procedures were in accordance with the animal welfare guidelines of
the Max Planck Society. Lentiviral stock was injected into the hippocampus of
3-week-old mice (Dittgen et al., 2004). Two weeks later, acute transverse
hippocampal slices were prepared. EPSCs, evoked by Schaffer collateral
stimulation every 10 s, were recorded in CA1 neurons in the whole-cell
patch-clamp configuration at70 mV. Comparable amplitudes were obtained
with the same range of stimulus intensities in cells with or without manipulation
of the BRAG2 level. mGluR-LTD was induced chemically by (RS)-3,5-DHPG
(10 min, 100 mM, Biotrend), and NMDAR-LTD was induced by LFS (2.5 Hz,
6 min at50 mV) in presence of mGluR1 antagonist BAY 36-7620 and mGluR5
antagonist MPEP-HCl (20 mM and 10 mM, respectively, Tocris).
Statistical Analysis
All quantitative data are presented as mean ± SEM of at least three indepen-
dent replicates. A one-tailed Student’s t test was applied to calculate statistical
differences. The alpha level was set to 0.05.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and Supplemental Experi-
mental Procedures and can be found with this article online at doi:10.1016/
j.neuron.2010.05.003.
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